Fig. 1From: Estimating long-term clinical effectiveness and cost-effectiveness of HPV 16/18 vaccine in ChinaComparison of data generated from the model with the Chinese cancer registry report (a: CC incidence in rural, b: CC incidence in urban, c: CC mortality in rural, d: CC mortality in urban)Back to article page